MUMBAI, India, and GERMANTOWN, USA, Oct. 1, 2013 /PRNewswire/ --Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715), an international specialty pharmaceutical company focused on chronic diseases, through its subsidiary, and Intrexon Corporation (XON), a leader in synthetic biology, today announced the formation of a joint venture to develop controllable gene-based therapies for the treatment of ocular diseases that cause partial or total blindness in millions of people worldwide. Initial targets are dry age-related macular degeneration (AMD), glaucoma and retinitis pigmentosa.
The joint venture will leverage Sun Pharma's global capabilities and experience in developing and manufacturing complex dosage forms and specialty pharmaceuticals for niche therapy areas. Intrexon and Sun Pharma will share in both the financing of, and the revenues from, the joint venture.
Through an Exclusive Channel Collaboration (ECC), the joint venture will have access to Intrexon's full suite of proprietary synthetic biology technologies, including the RheoSwitch Therapeutic System (RTS) platform. RTS is a clinically validated method for controlling the location, concentration and timing of protein expression. RTS may address a long-standing limitation of current approaches by enabling patients to receive a targeted biologic therapy without having to endure a lifetime of injections.
In addition to the initial targets, the companies intend to further expand the future pipeline of targeted ocular diseases to potentially include wet AMD, macular edema, non-infectious uveitis and diabetic retinopathy.
Samuel Broder, M.D., Senior Vice President of Intrexon's Health Sector and former Director of the National Cancer Institute, noted that current treatments for major ocular disorders require frequent and often painful interventions that, at best, only slow the progression of the disease.
"Using our RTS platform, the goal is to engineer a gene-based ocular treatment in which the concentration, location and timing of protein expression can be controlled with small molecule therapy," Dr. Broder said. "In combination with Sun Pharma's tremendous development and manufacturing experience, we hope to produce a therapy that is minimally invasive as well as maximally effective in treating these debilitating diseases."
Dilip Shanghvi, Managing Director of Sun Pharma, said "We believe Intrexon's biotechnology capabilities will enable us to develop not one, but several highly effective, novel treatments for multiple ocular disorders where there is currently an unmet need. Through this partnership it is our goal to provide relief for millions of people who today have very few treatment options and little hope of preserving their vision."
Randal J. Kirk, Chairman and Chief Executive Officer of Intrexon, said the collaboration between Sun Pharma and Intrexon is a model relationship aligned to accelerate development and production of new bio-engineered therapies.
"Today, more people suffer from ocular diseases than cancer," Kirk said. "To address this immense unmet need, our innovative collaboration will unite Sun Pharma's global capability to develop and manufacture complex pharmaceuticals with Intrexon's proprietary cell and gene engineering technologies. We share Sun Pharma's enthusiasm for the potential of our venture to produce a pipeline of product opportunities aimed at well-validated therapeutic targets."
About Sun PharmaEstablished in 1983, listed since 1994 and headquartered in India, Sun Pharma (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world. In India, the company is a leader in niche therapy areas of psychiatry, neurology, cardiology, nephrology, gastroenterology, orthopedics and ophthalmology. The company has strong skills in product development, process chemistry, and manufacturing of complex API, as well as dosage forms. More information about the company can be found at http://www.sunpharma.com.
Original post:
Sun Pharma and Intrexon Form Joint Venture to Develop New Class of Therapeutics for Ocular Diseases
- Amarantus Announces Positive Orphan Data for MANF in Retinitis Pigmentosa - August 14th, 2013 [August 14th, 2013]
- Amarantus BioScience - “Ophthalmology: MANF’s Orphan Strategy Coming into Focus in Retinitis Pigmentosa” - August 14th, 2013 [August 14th, 2013]
- RiverDogs Donate $20,000 to MUSC Storm Eye Institute - August 14th, 2013 [August 14th, 2013]
- Casino mogul Steve Wynn donates $25 million to find cure for eye disease he has - August 14th, 2013 [August 14th, 2013]
- Explaining Retinitis Pigmentosa, RP - Video - August 14th, 2013 [August 14th, 2013]
- FIRATLI CLINIC ISTANBUL Retinitis Pigmentosa HeilungTunnelBlick) - Video - August 18th, 2013 [August 18th, 2013]
- Treatment for retinitis pigmentosa - Video - August 18th, 2013 [August 18th, 2013]
- FIRATLI CLINIC ISTANBUL Retinitis Pigmentosa Treatment DUTCH) - Video - August 20th, 2013 [August 20th, 2013]
- FIRATLI CLINIC AvtarEngland) A MUST WATCH FOR Retinitis Pigmentosa Treatment (+Visionfieldtest) - Video - August 20th, 2013 [August 20th, 2013]
- Argus® II Retinal Prosthesis System Gets Government Funding in Both USA and Europe - August 21st, 2013 [August 21st, 2013]
- Second Sight Medical Named 2014 Technology Pioneer - September 1st, 2013 [September 1st, 2013]
- Retinitis pigmentosa treated with acupuncture - Video - September 1st, 2013 [September 1st, 2013]
- Man Copes with Retinitis Pigmentosa - September 8th, 2013 [September 8th, 2013]
- Dompé Announces the Food and Drugs Administration (FDA) Has Granted Orphan Drug Designation to its rhNGF-based ... - September 11th, 2013 [September 11th, 2013]
- September is healthy aging month—keep your mind active with free talking books - September 12th, 2013 [September 12th, 2013]
- Visually-impaired educator helps guide New Caney students - September 13th, 2013 [September 13th, 2013]
- Bionic eye shines light on darkness - September 15th, 2013 [September 15th, 2013]
- Football fan’s quest helps him to savor his fading sight - September 15th, 2013 [September 15th, 2013]
- Whole DNA sequencing reveals mutations, new gene for blinding disease - September 16th, 2013 [September 16th, 2013]
- This Week in PNAS - September 17th, 2013 [September 17th, 2013]
- First Self-Powered Artificial Retina Could Allow Normal Visual Acuity and Restoration of Color Vision - September 17th, 2013 [September 17th, 2013]
- Bionic eye offers gift of sight - September 24th, 2013 [September 24th, 2013]
- Lesa Kretschmer, CEO of Florida Reading & Vision Technology Inc., Named Honorary Chair of the 2013 South Florida ... - September 26th, 2013 [September 26th, 2013]
- Blind Yuba City man: ‘I walk every day, rain or shine’ - September 30th, 2013 [September 30th, 2013]
- Sun Pharma ties up with US company to offer new treatment of ocular diseases - October 1st, 2013 [October 1st, 2013]
- Sun Pharma inks joint venture with Intrexon - October 2nd, 2013 [October 2nd, 2013]
- NIH Scientists Pursue New Therapies To Improve Rare Disease Drug Development - October 2nd, 2013 [October 2nd, 2013]
- New bionic eye may help restore some vision in blind - October 8th, 2013 [October 8th, 2013]
- Trio heading to B.C. to join finish of Craig Gives Back tour - October 8th, 2013 [October 8th, 2013]
- Simple urine test could help diagnose eye disease - October 9th, 2013 [October 9th, 2013]
- The Low Vision Exam: Low Vision Specialists of Maryland and Virginia #3: - Video - October 10th, 2013 [October 10th, 2013]
- Blind cyclist nearing Penticton - October 10th, 2013 [October 10th, 2013]
- Retinitis Pigmentosa: Almost normal vision after 12 months treatment - Video - October 10th, 2013 [October 10th, 2013]
- Kelly: Steve Lonegan's passion fueled by challenges - October 13th, 2013 [October 13th, 2013]
- Glasses for Macular Degeneration: Low Vision Specialists of Maryland and Virginia #5 - Video - October 13th, 2013 [October 13th, 2013]
- Simple blood or urine test to identify blinding disease - October 16th, 2013 [October 16th, 2013]
- Blind Florida running back reaches the end zone during game - October 18th, 2013 [October 18th, 2013]
- Retinal Prosthesis System: 2014 Medical Innovation No. 1 - Video - October 20th, 2013 [October 20th, 2013]
- RetroSense Therapeutics Selected by Windhover as a “Top Project to Watch: Most Licensable Product” - October 28th, 2013 [October 28th, 2013]
- Retinitis Pigmentosa Treatment - October 31st, 2013 [October 31st, 2013]
- Retinitis pigmentosa - Genetics Home Reference - October 31st, 2013 [October 31st, 2013]
- Retinitis Pigmentosa Symptoms, Signs, Treatment, Causes, Research ... - October 31st, 2013 [October 31st, 2013]
- Foundation Fighting Blindness - What is Retinitis Pigmentosa? - October 31st, 2013 [October 31st, 2013]
- Retinitis pigmentosa - RNIB - RNIB - supporting blind and ... - October 31st, 2013 [October 31st, 2013]
- Retinitis pigmentosa: MedlinePlus Medical Encyclopedia - November 9th, 2013 [November 9th, 2013]
- Retinitis pigmentosa - National Library of Medicine - PubMed Health - November 11th, 2013 [November 11th, 2013]
- Retinitis Pigmentosa 11-06-2013 - Video - November 13th, 2013 [November 13th, 2013]
- Retinitis Pigmentosa treatment - acunova eye acupuncture after John Boel - Video - November 14th, 2013 [November 14th, 2013]
- Retinitis pigmentosa - Wikipedia, the free encyclopedia - November 21st, 2013 [November 21st, 2013]
- Retinitis pigmentosa | University of Maryland Medical Center - November 21st, 2013 [November 21st, 2013]
- Retinitis Pigmentosa - Low Vision - November 23rd, 2013 [November 23rd, 2013]
- Retinitis Pigmentosa or RP - AllAboutVision.com - November 26th, 2013 [November 26th, 2013]
- Retinitis Pigmentosa - Video - December 9th, 2013 [December 9th, 2013]
- RP International Spreads Holiday Cheer with The Eyes of Christmas™ - December 12th, 2013 [December 12th, 2013]
- UT Dallas Materials Scientist Research Contributes to Invention Recognized by Time Magazine - December 19th, 2013 [December 19th, 2013]
- Time is short, and sight is precious, for Sydney family living under shadow of mystery disease - December 19th, 2013 [December 19th, 2013]
- Me Driving (Prt 2) - Video - December 23rd, 2013 [December 23rd, 2013]
- Treatment of Retinitis Pigmentosa: normal vision after 9 months - Video - December 28th, 2013 [December 28th, 2013]
- Seeing Tomorrow - Video - January 1st, 2014 [January 1st, 2014]
- Edible batteries to power pacemakers + more - January 2nd, 2014 [January 2nd, 2014]
- How to cure blindness, concussions and baldness - January 2nd, 2014 [January 2nd, 2014]
- Matthew unlocks the iPad for blind and partially-sighted - January 4th, 2014 [January 4th, 2014]
- How poor eyesight led to a great vision - January 5th, 2014 [January 5th, 2014]
- Tea Thyme in Texas fundraiser set to be held at The Overlook - January 10th, 2014 [January 10th, 2014]
- Ballard author has hope that heals - January 11th, 2014 [January 11th, 2014]
- Distance runner knows the joy of competition - January 14th, 2014 [January 14th, 2014]
- Gene Therapy Tested as a Way to Stop Blindness - January 16th, 2014 [January 16th, 2014]
- Treatment may save thousands from blindness - January 16th, 2014 [January 16th, 2014]
- Gene therapy gives sight back to patients due to go blind - January 16th, 2014 [January 16th, 2014]
- Gene Therapy May Restore Sight in People With Rare Blinding Disease - January 16th, 2014 [January 16th, 2014]
- Blind Civil Rights Attorney, Athlete To Speak At Chabad House - January 17th, 2014 [January 17th, 2014]
- Visual Field Test results 4- Medical Evidence of Retinitis Pigmentosa Treatment- FIRATLI CLINIC - Video - January 20th, 2014 [January 20th, 2014]
- Gesichtsfeldtests 2- Retinitis Pigmentosa Behandlung (Retinopathia Pigmentosa) - FIRATLI KLINIK - Video - January 20th, 2014 [January 20th, 2014]
- Visual Field Test results 3-Medical Evidence of Retinitis Pigmentosa Treatment- FIRATLI CLINIC - Video - January 21st, 2014 [January 21st, 2014]
- Visual Field Test Results 2- Retinitis Pigmentosa Treatment- FIRATLI CLINIC - Video - January 21st, 2014 [January 21st, 2014]
- Visual field test results 1-Medical Evidence of Retinitis Pigmentosa Treatment- FIRATLI CLINIC - Video - January 21st, 2014 [January 21st, 2014]
- Mass. Eye and Ear physician awarded RPB Career Development Award - January 23rd, 2014 [January 23rd, 2014]
- Retinitis Pigmentosa Treatment / Behandlung- FIRATLI CLINIC Proof( Visual Field Test) Eng subtitle! - Video - January 23rd, 2014 [January 23rd, 2014]
- Retinitis Pigmentosa Treatment / Behandlung- FIRATLI CLINIC German with Eng.Subtitles - Video - January 23rd, 2014 [January 23rd, 2014]
- Visual Field Results 2-Medical Proof of Retinitis Pigmentosa Treatment- FIRATLI CLINIC - Video - January 27th, 2014 [January 27th, 2014]